1384439-79-5 Usage
Description
(S)-N-(2-(1-(3,4-dihydroxyphenyl)-2-(methylsulfonyl)ethyl)-1,3-dioxoisoindolin-4-yl)acetamide is a complex organic compound with a unique molecular structure. It is characterized by its dihydroxyphenyl and methylsulfonylethyl moieties, which contribute to its chemical properties and potential applications.
Uses
Used in Pharmaceutical Industry:
(S)-N-(2-(1-(3,4-dihydroxyphenyl)-2-(methylsulfonyl)ethyl)-1,3-dioxoisoindolin-4-yl)acetamide is used as a precursor in the synthesis of various pharmaceutical compounds. Its unique structure allows for the development of new drugs with potential therapeutic applications.
Used in Research and Development:
In the field of research and development, (S)-N-(2-(1-(3,4-dihydroxyphenyl)-2-(methylsulfonyl)ethyl)-1,3-dioxoisoindolin-4-yl)acetamide serves as a valuable compound for studying its chemical properties, reactivity, and potential interactions with biological systems. This knowledge can be applied to the design of new drugs and materials.
Related Compounds:
O4-Desmethyl O3-Desethyl Apremilast is a related compound of Apremilast, which is an oral phosphodiesterase 4 inhibitor used for treating psoriatic arthritis. Apremilast is also recognized as an anti-inflammatory agent, highlighting the potential therapeutic applications of compounds with similar structures to (S)-N-(2-(1-(3,4-dihydroxyphenyl)-2-(methylsulfonyl)ethyl)-1,3-dioxoisoindolin-4-yl)acetamide.
Check Digit Verification of cas no
The CAS Registry Mumber 1384439-79-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,8,4,4,3 and 9 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1384439-79:
(9*1)+(8*3)+(7*8)+(6*4)+(5*4)+(4*3)+(3*9)+(2*7)+(1*9)=195
195 % 10 = 5
So 1384439-79-5 is a valid CAS Registry Number.
1384439-79-5Relevant articles and documents
PHENETHYLSULFONE ISOINDOLINE DERIVATIVES AND THEIR USE
-
, (2012/07/27)
Provided are phenethyl isoindoline compounds, and pharmaceutically acceptable salts, solvates, or stereoisomers thereof. Methods of use and pharmaceutical compositions of these compounds are also disclosed.
